Mercer Capital Advisers’s Core Laboratories CLB Stock Holding History

Mercer Capital Advisers’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-100	Closed	-$12K	–	260
2017 Q1	$12K	Hold	100	–	–	0.01%	221
2016 Q4	$12K	Hold	100	–	–	0.01%	222
2016 Q3	$11K	Hold	100	–	–	0.01%	233
2016 Q2	$12K	Hold	100	–	–	0.01%	230
2016 Q1	$11K	Hold	100	–	–	0.01%	229
2015 Q4	$11K	Hold	100	–	–	0.01%	239
2015 Q3	$10K	Hold	100	–	–	0.01%	236
2015 Q2	$11K	Hold	100	–	–	0.01%	247
2015 Q1	$10K	Buy	+100	New	+$10.7K	0.01%	251

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mercer Capital Advisers's CLB Position: Q2 2017 in Review

Mercer Capital Advisers sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 100 shares — an estimated $12K sold.

Mercer Capital Advisers first reported a position in CLB in Q1 2015 and held it in 9 quarters. The position peaked at $12K in Q1 2017. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

Mercer Capital Advisers reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
Mercer Capital Advisers sold 100 Core Laboratories shares in Q2 2017, an estimated $12K.
Mercer Capital Advisers first reported a position in Core Laboratories in Q1 2015 and held it in 9 quarters.
Mercer Capital Advisers's Core Laboratories position peaked at $12K in Q1 2017.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Mercer Capital Advisers's 13F filing for Q2 2017, filed 31 Jul 2017.